Skip to main content

/ PharmaMics/ Group items tagged data

Group items tagged

Filter: All | Bookmarks | Topics Simple Middle

ESMO 2019: BeiGene presents data on tislelizumab and pamiparib - 0 views

www.clinicaltrialsarena.com/...-on-tislelizumab-and-pamiparib

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #beigene #tislelizumab #pamiparib

shared by ramchintamaneni on 17 Oct 19 - No Cached

ramchintamaneni on 17 Oct 19

Biopharmaceutical company BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab and PARP inhibitor pamiparib.

<div class="cArrow"> </div><div class="cContentInner">Biopharmaceutical company BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab and PARP inhibitor pamiparib.</div>

...

Cancel

EMA announces final steps for its clinical-trial data policy - 1 views

processandproduction.pharmaceutical-business-review.com/...ial-data-policy-090414-4211660

shared by Alex Parker on 09 Apr 14 - No Cached

Alex Parker on 09 Apr 14

EMA will launch a final round of targeted consultations with key stakeholders on its draft policy on proactive publication of and access to clinical-trial data at the beginning of May 2014.

<div class="cArrow"> </div><div class="cContentInner">EMA will launch a final round of targeted consultations with key stakeholders on its draft policy on proactive publication of and access to clinical-trial data at the beginning of May 2014.</div>

...

Cancel

ESMO 2019: ImmunoGen's ovarian cancer drug fails to meet PFS - 0 views

www.clinicaltrialsarena.com/...esmo-immunogen

#esmo2019 #esmocongress #esmoconference #ovariancancer #medicalnews #medicalindustry

shared by ramchintamaneni on 07 Oct 19 - No Cached

ramchintamaneni on 07 Oct 19

ImmunoGen has presented full data from Phase 3 Forward I study of Mirvetuximab Soravtansine in ovarian cancer at the ESMO 2019 Congress in Barcelona, Spain.

<div class="cArrow"> </div><div class="cContentInner">ImmunoGen has presented full data from Phase 3 Forward I study of Mirvetuximab Soravtansine in ovarian cancer at the ESMO 2019 Congress in Barcelona, Spain.</div>

...

Cancel

ESMO 2019: mCRC drug meets endpoints in Pfizer study - 0 views

www.clinicaltrialsarena.com/...crc-drug-meets-endpoint-pfizer

#cancertreatment #esmo2019 #esmocongress #esmoconference #esmocongress2019 #pfizer #mcrc #Colorectalcancer

shared by ramchintamaneni on 22 Oct 19 - No Cached

ramchintamaneni on 22 Oct 19

Pfizer has reported positive data from the interim analysis of the Phase III BEACON CRC clinical study being conducted to assess Braftovi.

<div class="cArrow"> </div><div class="cContentInner">Pfizer has reported positive data from the interim analysis of the Phase III BEACON CRC clinical study being conducted to assess Braftovi.</div>

...

Cancel

Bristol-Myers Squibb: Phase III CheckMate-227, Part 1 study ESMO 2019 - 0 views

www.pharmaceutical-technology.com/...esmo-2019-bristol-myers-squibb

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #bristolmyerssquibb #bms #NSCLC #cancertreatment

shared by ramchintamaneni on 21 Oct 19 - No Cached

ramchintamaneni on 21 Oct 19

Final data from BMS's Phase III CheckMate-227, Part 1 study was presented at the European Society of Medical Oncology conference in September.

<div class="cArrow"> </div><div class="cContentInner">Final data from BMS's Phase III CheckMate-227, Part 1 study was presented at the European Society of Medical Oncology conference in September.</div>

...

Cancel

Ireland gets a new Tramore laboratory for DNA sequencing service - 0 views

contractresearch.pharmaceutical-business-review.com/...tory-in-ireland-040214-4171387

shared by Alex Parker on 05 Feb 14 - No Cached

Alex Parker on 05 Feb 14

The new Tramore laboratory, which is key to the growth of the company's DNA sequencing service in Ireland, is positioned between Cork and Dublin, providing an opportunity to expand the Overnight Shipment service to all areas of the country, allowing customers across Ireland to access their sequencing data within 24 hours.

<div class="cArrow"> </div><div class="cContentInner">The new Tramore laboratory, which is key to the growth of the company's DNA sequencing service in Ireland, is positioned between Cork and Dublin, providing an opportunity to expand the Overnight Shipment service to all areas of the country, allowing customers across Ireland to access their sequencing data within 24 hours.</div>

...

Cancel

1 - 7 of 7

Showing 20▼ items per page

Related searches